Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks

Xiao Ling Li1, Matthew F Jones1, Murugan Subramanian1

  • 1Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

FEBS Letters
|April 15, 2014
PubMed

Insights

Mutant p53 proteins can drive cancer by altering microRNA expression. This review explores how these microRNAs control oncogenic functions and gene networks, impacting cancer progression.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression, influencing cell proliferation, differentiation, and apoptosis.
  • The p53 protein, crucial in tumor suppression, is frequently mutated in human cancers.
  • Mutant p53 can gain oncogenic functions distinct from wild-type p53 activity.

Purpose of the Study:

  • To review recent evidence on how mutant p53 proteins regulate specific microRNAs.
  • To elucidate the oncogenic functions acquired by mutant p53 through microRNA modulation.
  • To identify the gene networks controlled by microRNAs downstream of mutant p53.

Main Methods:

  • Literature review of recent studies on mutant p53 and microRNA regulation.
  • Analysis of experimental data linking mutant p53 to microRNA expression changes.
  • Bioinformatic identification of gene networks regulated by identified microRNAs.

Main Results:

  • Specific microRNAs are dysregulated by mutant p53 proteins.
  • These microRNAs contribute to the oncogenic functions of mutant p53.
  • A novel gene network regulated by mutant p53-downstream microRNAs has been identified.

Conclusions:

  • Mutant p53 utilizes microRNA regulation to promote cancer development.
  • Targeting these mutant p53-regulated microRNAs may offer new therapeutic strategies.
  • Understanding these networks is crucial for cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K